Wird geladen...
Sclerostin antibodies in osteoporosis: latest evidence and therapeutic potential
Sclerostin is an osteocyte-derived glycoprotein that inhibits Wnt/β-catenin signaling and activation of osteoblast function, thereby inhibiting bone formation. It plays a vital role in the regulation of skeletal growth. In adults, sclerostin secretion is modulated by skeletal loading (increased secr...
Gespeichert in:
| Veröffentlicht in: | Ther Adv Musculoskelet Dis |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publications
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5613857/ https://ncbi.nlm.nih.gov/pubmed/28974988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X17726744 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|